Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (81-90 of 512) with videos related to

Pageof 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?Diego Enrico, Angelo Paci, Nathalie Chaput, et al.
Cancers|July 9, 2022
Radon and Lung Cancer: Current Trends and Future PerspectivesMariona Riudavets, Marta Garcia de Herreros, Benjamin Besse, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Quantification of circulating vascular endothelial growth factor receptor-3-positive lymphatic/vascular endothelial progenitor cellsFrancoise Farace, Melissa Taylor, Jochen Rössler, et al.
International Journal of Clinical Pharmacy|May 11, 2018
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapyFlorian Slimano, Florence Netzer, Isabelle Borget, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2015
A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non-Small-Cell Lung CancerJosette Biya, Caroline Caramella, Colin R Lindsay, et al.
Nature Reviews. Clinical Oncology|August 16, 2018
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patientMaria Gion, Jordi Remon, Caroline Caramella, et al.
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation following administration of sunitinibAnaëlle Olivo, Nicolas Noël, Benjamin Besse, et al.
Investigational New Drugs|February 20, 2016
A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinibLinda Mahjoubi, Anas Gazzah, Benjamin Besse, et al.
Pageof 52

Showing results (81-90 of 512) with videos related to

Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?Diego Enrico, Angelo Paci, Nathalie Chaput, et al.
Cancers|July 9, 2022
Radon and Lung Cancer: Current Trends and Future PerspectivesMariona Riudavets, Marta Garcia de Herreros, Benjamin Besse, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Quantification of circulating vascular endothelial growth factor receptor-3-positive lymphatic/vascular endothelial progenitor cellsFrancoise Farace, Melissa Taylor, Jochen Rössler, et al.
International Journal of Clinical Pharmacy|May 11, 2018
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapyFlorian Slimano, Florence Netzer, Isabelle Borget, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2015
A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non-Small-Cell Lung CancerJosette Biya, Caroline Caramella, Colin R Lindsay, et al.
Nature Reviews. Clinical Oncology|August 16, 2018
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patientMaria Gion, Jordi Remon, Caroline Caramella, et al.
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation following administration of sunitinibAnaëlle Olivo, Nicolas Noël, Benjamin Besse, et al.
Investigational New Drugs|February 20, 2016
A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinibLinda Mahjoubi, Anas Gazzah, Benjamin Besse, et al.
Pageof 52